Debt-to-equity of Annovis Bio, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Annovis Bio, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Annovis Bio, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 22%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Annovis Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 22% +769% 30 Sep 2025
Q2 2025 30% +667% 30 Jun 2025
Q1 2025 55% -158% -74% 31 Mar 2025
Q4 2024 265% +192% +264% 31 Dec 2024
Q3 2024 -746% -771% -3119% 30 Sep 2024
Q2 2024 -637% -654% -3834% 30 Jun 2024
Q1 2024 213% +199% +1433% 31 Mar 2024
Q4 2023 73% +64% +714% 31 Dec 2023
Q3 2023 25% +21% +489% 30 Sep 2023
Q2 2023 17% +14% +452% 30 Jun 2023
Q1 2023 14% +11% +417% 31 Mar 2023
Q4 2022 9% +5.4% +153% 31 Dec 2022
Q3 2022 4.2% +0.29% +7.4% 30 Sep 2022
Q2 2022 3.1% -1.7% -36% 30 Jun 2022
Q1 2022 2.7% -7.7% -74% 31 Mar 2022
Q4 2021 3.6% -2.7% -44% 31 Dec 2021
Q3 2021 3.9% -17% -81% 30 Sep 2021
Q2 2021 4.8% 30 Jun 2021
Q1 2021 10% 31 Mar 2021
Q4 2020 6.3% 31 Dec 2020
Q3 2020 21% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.